Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case–control study

References

• Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;30326:298–304
   Google Scholar
• Larché M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003;111:450–463
   PubMed Web of Science ®Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program: the global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469–478
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev 2003;14:511–522
   PubMed Web of Science ®Google Scholar
• Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546–3556
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol 2002;42:81–98
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209–1220
   PubMed Web of Science ®Google Scholar
• Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 1993;151:2390–2398
   PubMed Web of Science ®Google Scholar
• Becker JC, Czerny C, Bröcker EB. Maintenance of clonal anergy by endogenously produced IL-10. Int Immunol 1994;6:1605–1612
   PubMed Web of Science ®Google Scholar
• Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M. Interleukin 10 inhibits lipopolysaccharide -induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994;180:711–715
   PubMed Web of Science ®Google Scholar
• Punnonen J, de Waal Malefyt R, van Vlasselaer P, Gauchat JF, de Vries JE. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993;151:1280–1289
   PubMed Web of Science ®Google Scholar
• Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999;54:825–857
   PubMed Web of Science ®Google Scholar
• Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479–490
   PubMed Web of Science ®Google Scholar
• Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, Okayama Y, Saito H, et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 2007;87:971–978
   PubMed Web of Science ®Google Scholar
• Moulin D, Donzé O, Talabot-Ayer D, Mézin F, Palmer G, Gabay C. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007;40:216–225
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Smith DE, Comeau MR, Delespesse G. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007;179:2051–2054
   PubMed Web of Science ®Google Scholar
• Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009;179:772–781
   PubMed Web of Science ®Google Scholar
• John M, Au BT, Jose PJ, Lim S, Saunders M, Barnes PJ, Mitchell JA, et al. Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol 1998;18:84–90
   Google Scholar
• Bernstein DI, Cartier A, Côté J, Malo JL, Boulet LP, Wanner M, Milot J, et al. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 2002;166:445–450
   PubMed Web of Science ®Google Scholar
• Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol 1998;102:265–274
   PubMedGoogle Scholar
• Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, Howarth PH. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997;156:642–647
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. IL-17 cytokine family. J Allergy Clin Immunol 2004;114:1265–1273
   PubMed Web of Science ®Google Scholar
• Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011;127:701–721
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, et al. Standardisation of spirometry. Eur Respir J 2005;26:319–338
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143–178
   PubMed Web of Science ®Google Scholar
• Antunes J, Borrego L, Romeira A, Pinto P. Skin prick tests and allergy diagnosis. Allergol Immunopathol (Madr) 2009;37:155–164
   PubMed Web of Science ®Google Scholar
• Aas K, Belin L. Standardization of diagnostic work in allergy. Int Arch Allergy Appl Immunol 1973;45:57–60
   PubMedGoogle Scholar
• Kim CK, Kim SW, Park CS, Kim BI, Kang H, Koh YY. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol 2003;112:64–71
   PubMed Web of Science ®Google Scholar
• Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, McCormick M, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010;138:1140–1147
   PubMed Web of Science ®Google Scholar
• Currie GP, Fardon TC, Lee DK. The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma. Ther Clin Risk Manag 2005;1:83–92
   Google Scholar
• Pukelsheim K, Stoeger T, Kutschke D, Ganguly K, Wjst M. Cytokine profiles in asthma families depend on age and phenotype. PLoS One 2010;5:e14299
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol 2002;42:81–98
   PubMed Web of Science ®Google Scholar
• Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996;97:1288–1296
   PubMed Web of Science ®Google Scholar
• Gupta A, Dimeloe S, Richards DF, Chambers ES, Black C, Urry Z, Ryanna K, et al. Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma. Thorax 2014;69:508–15
   Google Scholar
• John M, Lim S, Seybold J, Jose P, Robichaud A, O'Connor B, Barnes PJ, et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte–macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998;157:256–262
   PubMed Web of Science ®Google Scholar
• Liu M, Liu K, Zhu N, Xia J, Chen X. Inflammatory mediators in induced sputum and airway hyperresponsiveness in cough variant asthma during long-term inhaled corticosteroid treatment. Mediators Inflamm 2012;2012:403868
   PubMed Web of Science ®Google Scholar
• Cao Y, Gong W, Zhang H, Liu B, Li B, Wu X, Duan X, et al. A comparison of serum and sputum inflammatory mediator profiles in patients with asthma and COPD. J Int Med Res 2012;40:2231–2242
   Google Scholar
• Yalcin AD, Bisgin A, Gorczynski RM. IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment. Mediators Inflamm 2012;2012:720976
   PubMed Web of Science ®Google Scholar
• Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CW. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001;125:177–183
   PubMed Web of Science ®Google Scholar
• Ceyhan BB, Enc FY, Sahin S. IL-2 and IL-10 levels in induced sputum and serum samples of asthmatics. J Investig Allergol Clin Immunol 2004;14:80–85
   Google Scholar
• Stelmach I, Jerzyńska J, Bobrowska M, Brzozowska A, Majak P, Kuna P. IL-10 serum levels in children with moderate asthma. Pneumonol Alergol Pol 2002;70:25–33
   Google Scholar
• Yssel H, De Waal Malefyt R, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, de Vries JE. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992;149:2378–2384
   PubMed Web of Science ®Google Scholar
• Kawaguchi M, Onuchic LF, Li XD, Essayan DM, Schroeder J, Xiao HQ, Liu MC, et al. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 2001;167:4430–4435
   PubMed Web of Science ®Google Scholar
• Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, Barber MC, Wang W, et al. A novel cytokine receptor–ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 2000;275:19167–19176
   PubMed Web of Science ®Google Scholar
• Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, Wang YH, et al. Regulation of inflammatory responses by IL-17F. J Exp Med 2008;205:1063–1075
   PubMed Web of Science ®Google Scholar
• Al-Ramli W, Préfontaine D, Chouiali F, Martin JG, Olivenstein R, Lemière C, Hamid Q. T (H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009;123:1185–1187
   PubMed Web of Science ®Google Scholar
• Kokubu F, Matsukura S, Kawaguchi M, Osakabe Y. Respiratory viruses and bronchial asthma. Arerugi 2008;57:1117–1123
   Google Scholar
• Bazzi MD, Sultan MA, Al Tassan N, Alanazi M, Al-Amri A, Al-Hajjaj MS, Al-Muhsen S, et al. Interleukin 17A and F and asthma in Saudi Arabia: gene polymorphisms and protein levels. J Investig Allergol Clin Immunol 2011;21:551–555
   PubMed Web of Science ®Google Scholar
• Fujita J, Kawaguchi M, Kokubu F, Ohara G, Ota K, Huang SK, Morishima Y, et al. Interleukin-33 induces interleukin-17F in bronchial epithelial cells. Allergy 2012;67: 744–7450
   Google Scholar
• de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992;4:314–320
   PubMed Web of Science ®Google Scholar
• Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444–3451
   PubMed Web of Science ®Google Scholar
• Groux H, Bigler M, de Vries JE, Roncarolo MG. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol 1998;160:3188–3193
   PubMed Web of Science ®Google Scholar
• Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 2010;10:225–235
   PubMed Web of Science ®Google Scholar
• Deo SS, Mistry KJ, Kakade AM, Niphadkar PV. Role played by Th2 type cytokines in IgE mediated allergy and asthma. Lung India 2010;27:66–71
   Google Scholar
• Shi YH, Shi GC, Wan HY, Jiang LH, Ai XY, Zhu HX, Tang W, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin Med J (Engl) 2011;124:1951–1956
   Google Scholar
• Rudha Abbas SA. Comparative study of Interleukin-33 in Male with Chronic Obstructive Pulmonary Disease, Asthmatic Patients with Type2diabetes mellitus. International Journal of Innovative Research in Science, Engineering and Technology 2013;2:5947–5954
   Google Scholar
• Azazi EA, Elshora AE, Tantawy EA, Elsayd MA. Serum levels of Interleukin-33 and its soluble receptor ST2 in asthmatic patients. Egyptian Journal of Chest Diseases and Tuberculosis 2013; 63:279–284
   Google Scholar
• Yang DX, Li N, Zhang XL, Wang Q. Serum interleukin 18 and 33 levels and its clinical significance in asthma patients. Zhonghua Jie He He Hu Xi Za Zhi 2012;35:493–496
   Google Scholar
• Préfontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010;125:752–754
   PubMed Web of Science ®Google Scholar
• Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemière C, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009;183:5094–5103
   PubMed Web of Science ®Google Scholar
• Hamzaoui A, Berraies A, Kaabachi W, Haifa M, Ammar J, Kamel H. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children. J Asthma 2013;50:803–809
   PubMed Web of Science ®Google Scholar
• Mato N, Bando M, Yamasawa H, Hosono T, Mizushina Y, Sata M, Ohki G, et al. Role of IL-33 in bronchial asthma. Nihon Kokyuki Gakkai Zasshi 2010;48:419–425
   PubMedGoogle Scholar
• Dente FL, Carnevali S, Bartoli ML, Cianchetti S, Bacci E, Di Franco A, Vagaggini B, et al. Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients. Ann Allergy Asthma Immunol 2006;97:312–320
   PubMed Web of Science ®Google Scholar
• Shute JK, Vrugt B, Lindley IJ, Holgate ST, Bron A, Aalbers R, Djukanović R. Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997;155:1877–1883
   PubMed Web of Science ®Google Scholar
• Yamashita N, Tashimo H, Ishida H, Kaneko F, Nakano J, Kato H, Hirai K, et al. Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). Cell Immunol 2002;219:92–97
   PubMed Web of Science ®Google Scholar
• Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997;156:1377–1383
   PubMed Web of Science ®Google Scholar
• Almirall JJ, Páez I. Interpretation of spirometric tests in asthmatic patients with reduced forced vital capacity. J Investig Allergol Clin Immunol 1994;4:258–260
   Google Scholar
• Girdhar A, Kumar V, Singh A, Menon B, Vijayan VK. Systemic inflammation and its response to treatment in patients with asthma. Respir Care 2011;56:800–805
   Google Scholar
• Chang SH, Dong C. IL-17F: regulation, signaling and function in inflammation. Cytokine 2009;46:7–11
   PubMedGoogle Scholar
• Hayashi H, Kawakita A, Okazaki S, Yasutomi M, Murai H, Ohshima Y. IL-17A/F modulates fibrocyte functions in cooperation with CD40-mediated signaling. Inflammation 2013;36:830–838
   PubMed Web of Science ®Google Scholar
• Tateno H, Nakamura H, Minematsu N, Nakajima T, Takahashi S, Nakamura M, Fukunaga K, et al. Plasma eotaxin level and severity of asthma treated with corticosteroid. Respir Med 2004;98:782–790
   PubMedGoogle Scholar
• Friebe A, Volk HD. Stability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activation. Arch Pathol Lab Med 2008;132:1802–1806
   PubMed Web of Science ®Google Scholar